Literature DB >> 24980276

Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.

M Giannella1, E M Trecarichi, F G De Rosa, V Del Bono, M Bassetti, R E Lewis, A R Losito, S Corcione, C Saffioti, M Bartoletti, G Maiuro, C S Cardellino, S Tedeschi, R Cauda, C Viscoli, P Viale, M Tumbarello.   

Abstract

Knowledge of carbapenem-resistant Klebsiella pneumoniae (CR-KP) colonization is important to prevent nosocomial spread but also to start prompt adequate antibiotic therapy in patients with suspicion of infection. However, few studies have examined the incidence and risk factors for CR-KP bloodstream infection (BSI) among rectal carriers. To identify risk factors for CR-KP BSI among carriers, we performed a multicentre prospective matched case-control study of all adult CR-KP rectal carriers hospitalized in five tertiary teaching hospitals in Italy over a 2-year period. Carriers who developed CR-KP BSI were compared with those who did not develop subsequent BSI. Overall, 143 CR-KP BSIs were compared with 572 controls without a documented infection during their hospitalization. Multivariate analysis revealed that admission to the Intensive Care Unit (ICU) (OR, 1.65; 95% CI, 1.05-2.59; p 0.03), abdominal invasive procedure (OR, 1.87; 95% CI, 1.16-3.04; p 0.01), chemotherapy/radiation therapy (OR, 3.07; 95% CI, 1.78-5.29; p <0.0001), and number of additional colonization sites (OR, 3.37 per site; 95% CI, 2.56-4.43; p <0.0001) were independent risk factors for CR-KP BSI development among CR-KP rectal carriers. A CR-KP BSI risk score ranging from 0 to 28 was developed based on these four independent variables. At a cut-off of ≥2 the model exhibited a sensitivity, specificity, positive predictive value and negative predictive value of 93%, 42%, 29% and 93%, respectively. Colonization at multiple sites with CR-KP was the strongest predictor of BSI development in our large cohort of CR-KP rectal carriers.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Bloodstream infection; carbapenem resistance; colonization status; rectal carriers

Mesh:

Substances:

Year:  2014        PMID: 24980276     DOI: 10.1111/1469-0691.12747

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  61 in total

Review 1.  Bloodstream infections in the Intensive Care Unit.

Authors:  Matteo Bassetti; Elda Righi; Alessia Carnelutti
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

2.  Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement.

Authors:  Corrado Girmenia; Claudio Viscoli; Alfonso Piciocchi; Laura Cudillo; Stefano Botti; Antonio Errico; Loredana Sarmati; Fabio Ciceri; Franco Locatelli; Maddalena Giannella; Matteo Bassetti; Carlo Tascini; Letizia Lombardini; Ignazio Majolino; Claudio Farina; Francesco Luzzaro; Gian Maria Rossolini; Alessandro Rambaldi
Journal:  Haematologica       Date:  2015-04-10       Impact factor: 9.941

3.  Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study.

Authors:  D R Giacobbe; V Del Bono; P Bruzzi; S Corcione; M Giannella; A Marchese; L Magnasco; A E Maraolo; N Pagani; C Saffioti; S Ambretti; C S Cardellino; E Coppo; F G De Rosa; P Viale; C Viscoli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-01       Impact factor: 3.267

4.  Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae.

Authors:  Elizabeth Diago-Navarro; Isabel Calatayud-Baselga; Donglei Sun; Camille Khairallah; Inderjit Mann; Amaia Ulacia-Hernando; Brian Sheridan; Meiqing Shi; Bettina C Fries
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

5.  De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome.

Authors:  Giulia la Martire; Christine Robin; Nadia Oubaya; Raphaël Lepeule; Florence Beckerich; Mathieu Leclerc; Walid Barhoumi; Andréa Toma; Cécile Pautas; Sébastien Maury; Wiem Akrout; Catherine Cordonnier-Jourdin; Vincent Fihman; Mario Venditti; Catherine Cordonnier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-26       Impact factor: 3.267

6.  Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.

Authors:  C Hauck; E Cober; S S Richter; F Perez; R A Salata; R C Kalayjian; R R Watkins; N M Scalera; Y Doi; K S Kaye; S Evans; V G Fowler; R A Bonomo; D van Duin
Journal:  Clin Microbiol Infect       Date:  2016-02-03       Impact factor: 8.067

7.  Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study.

Authors:  Maddalena Giannella; Elena Graziano; Lorenzo Marconi; Nicolo Girometti; Michele Bartoletti; Sara Tedeschi; Fabio Tumietto; Francesco Cristini; Simone Ambretti; Andrea Berlingeri; Russell E Lewis; Pierluigi Viale
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-01       Impact factor: 3.267

8.  Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance.

Authors:  Jeffrey R Strich; Emily L Heil; Henry Masur
Journal:  J Infect Dis       Date:  2020-07-21       Impact factor: 5.226

9.  Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection.

Authors:  Guido Bertolini; Giovanni Nattino; Carlo Tascini; Daniele Poole; Bruno Viaggi; Greta Carrara; Carlotta Rossi; Daniele Crespi; Matteo Mondini; Martin Langer; Gian Maria Rossolini; Paolo Malacarne
Journal:  Intensive Care Med       Date:  2018-09-25       Impact factor: 17.440

Review 10.  Bloodstream infections in neutropenic cancer patients: A practical update.

Authors:  Giulia Gustinetti; Malgorzata Mikulska
Journal:  Virulence       Date:  2016-04-02       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.